New York Blood Cen­ter En­ter­pris­es buys Ta­laris’ cell ther­a­py fa­cil­i­ties in CD­MO ex­pan­sion

The New York Blood Cen­ter En­ter­pris­es (NY­BCe) is ab­sorb­ing two of Ta­laris Ther­a­peu­tics’ au­tol­o­gous and al­lo­gene­ic cell and gene ther­a­py fa­cil­i­ties to ex­pand its CD­MO …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER